Northwestern Mutual Investment Management Company LLC decreased its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 80.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,130 shares of the company’s stock after selling 12,880 shares during the quarter. Northwestern Mutual Investment Management Company LLC’s holdings in Henry Schein were worth $553,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently added to or reduced their stakes in the company. Lee Financial Co acquired a new position in Henry Schein in the second quarter valued at about $161,000. Westside Investment Management Inc. acquired a new position in Henry Schein in the first quarter valued at about $168,000. JNBA Financial Advisors acquired a new position in Henry Schein in the first quarter valued at about $170,000. Peddock Capital Advisors LLC lifted its stake in Henry Schein by 29.1% in the first quarter. Peddock Capital Advisors LLC now owns 1,097 shares of the company’s stock valued at $186,000 after buying an additional 247 shares during the period. Finally, Van ECK Associates Corp lifted its stake in Henry Schein by 5.7% in the first quarter. Van ECK Associates Corp now owns 1,138 shares of the company’s stock valued at $193,000 after buying an additional 61 shares during the period. 89.11% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This article was originally published by Stock Observer and is the property of of Stock Observer. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.thestockobserver.com/2017/09/13/northwestern-mutual-investment-management-company-llc-has-553000-holdings-in-henry-schein-inc-hsic.html.
Several equities analysts have weighed in on HSIC shares. Zacks Investment Research lowered Henry Schein from a “buy” rating to a “hold” rating in a research note on Friday, June 23rd. Credit Suisse Group reissued a “hold” rating and issued a $175.00 target price on shares of Henry Schein in a research note on Tuesday, August 29th. Stifel Nicolaus reissued a “hold” rating on shares of Henry Schein in a research note on Thursday, July 6th. Jefferies Group LLC reissued a “hold” rating and issued a $177.00 target price on shares of Henry Schein in a research note on Friday, July 21st. Finally, Piper Jaffray Companies started coverage on Henry Schein in a research note on Monday, June 12th. They issued a “neutral” rating and a $200.00 target price on the stock. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and six have given a buy rating to the stock. Henry Schein has an average rating of “Hold” and a consensus target price of $186.60.
Shares of Henry Schein, Inc. (NASDAQ HSIC) opened at 175.92 on Wednesday. Henry Schein, Inc. has a 12 month low of $146.23 and a 12 month high of $186.99. The firm has a market cap of $13.91 billion, a price-to-earnings ratio of 25.71 and a beta of 1.10. The company has a 50-day moving average price of $174.75 and a 200-day moving average price of $176.34. Henry Schein shares are scheduled to split before the market opens on Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly created shares will be issued to shareholders after the closing bell on Thursday, September 14th.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The business had revenue of $3.06 billion for the quarter, compared to the consensus estimate of $3.05 billion. During the same period in the prior year, the business earned $1.64 EPS. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. Analysts forecast that Henry Schein, Inc. will post $7.27 earnings per share for the current fiscal year.
In related news, SVP Paul Rose sold 2,126 shares of the company’s stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total transaction of $366,756.26. Following the transaction, the senior vice president now directly owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 1.27% of the stock is currently owned by corporate insiders.
Henry Schein Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.